文献速递胸部肿瘤放疗放疗物理与技术

RSPO3经NLRP3炎症小体介导的细胞焦亡调控非小细胞肺癌细胞放射抵抗

RSPO3 regulates the radioresistance of Non-Small cell lung cancer cells via NLRP3 Inflammasome-Mediated pyroptosis.
PubMed 文献 · Radiother Oncol · 2024-09-07

研究通过RNA测序发现放射抵抗的非小细胞肺癌细胞中RSPO3表达下调,过表达RSPO3经β-catenin-NF-κB通路和NLRP3炎症小体诱导细胞焦亡从而增加放射敏感性,体内实验中使用临床级抗RSPO3抗体可阻断辐射诱导的细胞焦亡和抗肿瘤免疫。

要点

  • 放射抵抗的非小细胞肺癌细胞中RSPO3表达下调。
  • 过表达RSPO3经β-catenin-NF-κB通路和NLRP3炎症小体诱导焦亡增加放射敏感性。
  • 作者认为靶向RSPO3-NLRP3炎症小体轴可能增强非小细胞肺癌放疗疗效。

核心结论

  • RSPO3通过NLRP3介导的细胞焦亡在调控非小细胞肺癌放射抵抗中起关键作用。
  • 作者认为靶向RSPO3-NLRP3炎症小体轴可能为增强非小细胞肺癌患者放疗疗效提供潜在治疗策略。

研究设计与样本

  • 研究对放射抵抗的非小细胞肺癌细胞系进行RNA测序分析差异表达基因。
  • 开展RSPO3过表达和敲低实验评估其对放射敏感性的影响。
  • 评估β-catenin-NF-κB信号通路和NLRP3炎症小体在RSPO3介导放射敏感性中的作用。
  • 使用临床级抗RSPO3抗体(OMP-131R10/rosmantuzumab)进行体内实验评估其对辐射诱导细胞焦亡及后续抗肿瘤免疫的影响。

主要发现

  • RSPO3在放射抵抗的非小细胞肺癌细胞中表达下调。
  • 过表达RSPO3通过诱导细胞焦亡增加非小细胞肺癌放射敏感性,该过程由β-catenin-NF-κB信号通路和NLRP3炎症小体介导。
  • 抗RSPO3抗体在体内有效阻断辐射诱导的细胞焦亡和抗肿瘤免疫。
  • 上调RSPO3增强非小细胞肺癌肿瘤放射敏感性。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Radioresistance is a significant challenge in the radiotherapy of non-small cell lung cancer (NSCLC). This study aimed to investigate the role of R-spondin 3 (RSPO3) in regulating NSCLC radioresistance. METHODS AND MATERIALS: RNA sequencing was performed to analyze genes that are differentially expressed in radioresistant NSCLC cell lines. RSPO3 overexpression and knockdown experiments were conducted to assess its impact on radiosensitivity. The involvement of the β-catenin-NF-κB signaling pathway and the NLRP3 inflammasome in RSPO3-mediated radiosensitivity was also evaluated. In vivo experiments were conducted using a clinical-grade anti-RSPO3 antibody (OMP-131R10/rosmantuzumab) to assess its impact on radiation-induced pyroptosis and subsequent anti-tumor immunity. RESULTS: RSPO3 expression was downregulated in radioresistant NSCLC cells. Overexpression of RSPO3 increased NSCLC radiosensitivity through the induction of pyroptosis, which was mediated by the β-catenin-NF-κB signaling pathway and the NLRP3 inflammasome. The anti-RSPO3 antibody effectively blocked radiation-induced pyroptosis and anti-tumor immunity in vivo. Conversely, upregulation of RSPO3 enhanced NSCLC tumor radiosensitivity. CONCLUSIONS: The findings demonstrated that RSPO3 plays a crucial role in regulating NSCLC radioresistance via NLRP3 mediated pyroptosis. Targeting the RSPO3-NLRP3 inflammasome axis may offer a potential therapeutic strategy to enhance the efficacy of radiotherapy for NSCLC patients.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Li H, Zhang J, Yu B, et al. RSPO3 regulates the radioresistance of Non-Small cell lung cancer cells via NLRP3 Inflammasome-Mediated pyroptosis. Radiother Oncol. 2024. PMID: 39245068. doi:10.1016/j.radonc.2024.110528

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。